Announcements Trials
Browse Landscape

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 32Observational 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 3Castrate Refractory Metastatic Prostate Cancer (mCRPC) 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × sipuleucel-T × Clear all
NCT02353715 2020-12-24

PEAX

Duke University

Completed
38 enrolled
Genitourinary

Prostatic Neoplasms

NCT01727154 2019-08-19

PRIME

Dendreon

Terminated
139 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT01306890 2019-06-07

PROCEED

Dendreon

Completed
1,976 enrolled 20 charts
Genitourinary

Prostatic Neoplasms

NCT02232230 2019-01-09

A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

GenesisCare USA

Completed
20 enrolled
Genitourinary

Castrate Refractory Metastatic Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡